Company Filing History:
Years Active: 2016
Title: Innovations in Cancer Treatment by Yueqiu Shen
Introduction
Yueqiu Shen is a notable inventor based in Beijing, China. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the use of Icaritin, a compound that shows promise in improving cancer therapies.
Latest Patents
Yueqiu Shen holds a patent for the "Use of Icaritin for the preparation of composition for treating cancer." This invention outlines a method for administering Icaritin orally to patients over a continuous 28-day dosing schedule. The recommended dosage ranges from 400 to 1800 mg daily. Patients treated with Icaritin using this method have reported better treatment outcomes with fewer adverse effects.
Career Highlights
Yueqiu Shen is associated with Beijing Shenogen Pharma Group Ltd., where he continues to advance his research in cancer treatment. His dedication to improving patient care through innovative solutions is evident in his work.
Collaborations
Yueqiu Shen collaborates with talented individuals such as Kun Meng and Hongxia Ding, who contribute to his research efforts and the development of new therapeutic strategies.
Conclusion
Yueqiu Shen's innovative approach to cancer treatment through the use of Icaritin highlights the potential for advancements in medical therapies. His contributions are paving the way for improved patient outcomes in the fight against cancer.